Richard Narido
Director Financiero/CFO en NRX PHARMACEUTICALS, INC. .
Cargos activos de Richard Narido
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NRX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 13/09/2023 | - |
Director Financiero/CFO | 13/09/2023 | - |
Historial de carrera de Richard Narido
Antiguos cargos conocidos de Richard Narido.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LUCIRA HEALTH, INC. | Comptroller/Controller/Auditor | 15/11/2022 | - |
Director Financiero/CFO | 15/11/2022 | 01/04/2023 | |
Corporate Officer/Principal | 01/03/2021 | - | |
ASSEMBLY BIOSCIENCES, INC. | Director/Miembro de la Junta | 01/07/2018 | 01/03/2021 |
Director Financiero/CFO | 01/07/2018 | 01/03/2021 | |
Treasurer | 01/07/2018 | 01/03/2021 | |
BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 01/06/2014 | 01/06/2018 |
MCKESSON CORPORATION | Corporate Officer/Principal | 01/01/2006 | 01/11/2010 |
Formación de Richard Narido.
University of San Francisco | Undergraduate Degree |
Pepperdine Graziadio Business School | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
2 |
Operativa
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
NRX PHARMACEUTICALS, INC. | Health Technology |
BIO-RAD LABORATORIES, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
MCKESSON CORPORATION | Distribution Services |
Empresas privadas | 1 |
---|---|
Lucira Health, Inc.
Lucira Health, Inc. Medical SpecialtiesHealth Technology Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Narido
- Experiencia